Clinical Trials
30 trialsImaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
St. Jude Children's Research Hospital
HER-CROWN
Ottawa Heart Institute Research Corporation
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
M.D. Anderson Cancer Center
Using Diagnostic Tools to Stage Breast Cancer
University of Pennsylvania
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
City of Hope Medical Center
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
City of Hope Medical Center
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Thomas Jefferson University
Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study
Kepler University Hospital
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer
City of Hope Medical Center
PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Ruijin Hospital
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
University of Washington
Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas
Memorial Sloan Kettering Cancer Center
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.
Istituto Clinico Humanitas
TEmPoRAL
Center Eugene Marquis
18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study
University Health Network, Toronto
PET/CT-Assessment of Liver Tumor Ablation
Dana-Farber Cancer Institute
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Case Comprehensive Cancer Center
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Case Comprehensive Cancer Center
The Diagnostic Value of PET/MRI in Head and Neck Cancer
Odense University Hospital
Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization
University of Southern California
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
MIMOPA
Cardiff University
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
Case Comprehensive Cancer Center
FDG-PET in Advanced Melanoma
Vanderbilt-Ingram Cancer Center
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
Virginia Commonwealth University